Medic Vision's iQMR reported 30% reduced brain exam scan time without adverse effects to image quality.
The US Food and Drug Administration (FDA) has granted marketing approval to the Medic Vision intelligent Quick MR (iQMR) product.
The product, an iterative image reconstruction system that uses new technology to enhance magnetic resonance imaging (MRI) images and signal-to-noise ratio (SNR), promotes capabilities that shortens common MRI protocol and improves patient experience. It functions as a centralized network-based add-on system that connects to all MRI scanners in a site's imaging derpartment via the Digital Imaging and Communications in Medicine (DICOM) network. It then automatically processes short-scan noisy MRI images and sends high-quality copies to the archiving sytem or other workstations. The iQMR can support MRI scanners of all vendors and models.
Medic Vision, developer of a line of 3D iterative image enhancement products since 2006, intends to showcase the iQMR at the upcoming American Society of Neuroradiology (ASNR) 56th Annual Meeting in Vancouver, BC, Canada from June 2-7. Included in its showcase will be results of a clinical study, in which the device reported 30% reduced brain exam scan time without adverse effects to image quality. According to the company, its products are based on sophisticated proprietary algorithms, and is prominently in clinical use at major hospitals and imaging centers nationwide.
With flagship CT products including SafeCT and SafeCT-29 being used in more than 500 US clinical sites, Medic Vision has “established its dominance” as the leading provider of third-party CT dose management and reduction solutions, chief executive officer Eyal Aharon said in a statement. According to Medic Vision, its approved devices have saved users more than $50 million in MRI-related costs in the past 12 years.